Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Surgical Technology _ Cardiovascular, Cardiac & Cardiology Companies

Cardiogenesis

Parents

*Architects: Surgical Robotics
*Architects: Surgical Technology _ Cardiovascular, Cardiac & Cardiology Companies
*Industry: Southern California
*OneMedPlace Conference: Architects- Investment/Strategic Partner Prospects
Companies: Acquired_(M&A)
Finance & Acquisitions: Cryolife

11 Musick
Cardiogenesis Corp. (CGCP.PK) develops and markets surgical products for the treatment of refractory angina in patients with dif
Clinical and market leader in TMR (Transmyocardial Revascularization) and leading the way in advanced combination angiogenic therapies for the treatment of severe angina.
CryoLife, Inc. Signs Definitive Agreement to Acquire Cardiogenesis Corporation in $22M Deal (2011)
Irvine, California
Irvine, California 92618
Paul McCormick, Executive Chairman
The company is focused on building utilization of the more than 350 laser install base and to initiate a US clinical trial for i
The company sells its Sologrip III (R) and PEARL 5.0 (TM) single use delivery systems for $4,395 and $5,950.
The company's key call points are the cardiovascular surgeon and the cardiologist.
The handpiece includes three 26 gauge needles positioned around the fiberoptic fibers, which allow precise delivery of biologic/
The PEARL 5.0 is compatible with the da Vinci (TM) surgical robot.
The PHOENIX handpiece is the first combination device specifically designed to allow tissue stimulation and physician-directed i
The PHOENIX includes an integral CrystalFlex (TM) fiber-optic component consisting of thirty-seven 100 m diameter fibers.